ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Trifluoroacetic acid → 3-(6-Chloro-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-8-oxa-3-azabicyclo[3.2.1]octane

HRID 1093178
印刷

反応式

HRID 1093178 の反応式
[CH:1]12[O:8][CH:5]([CH2:6][CH2:7]1)[CH2:4][N:3]([C:9]1[N:14]=[C:13]([Cl:15])[N:12]=[C:11]3[N:16]([CH:19]4[CH2:24][CH2:23][N:22]([C:25](OC(C)(C)C)=O)[CH2:21][CH2:20]4)[N:17]=[CH:18][C:10]=13)[CH2:2]2.F[C:33](F)(F)[C:34](O)=O.FC(F)(F)C([O-])=O.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[CH2:60]([N:62](CC)[CH2:63]C)[CH3:61]>ClCCl>[Cl:15][C:13]1[N:12]=[C:11]2[N:16]([CH:19]3[CH2:20][CH2:21][N:22]([CH2:25][C:61]4[CH:60]=[N:62][CH:63]=[CH:33][CH:34]=4)[CH2:23][CH2:24]3)[N:17]=[CH:18][C:10]2=[C:9]([N:3]2[CH2:2][CH:1]3[O:8][CH:5]([CH2:6][CH2:7]3)[CH2:4]2)[N:14]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 6422Trifluoroacetic acidHCID 8471TriethylamineHCID 84468TrifluoroacetateHCID 5049666Sodium triacetoxyborohydrideHCID 86629367tert-butyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-chloro-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate

生成物 1

HCID 86629369
3-(6-Chloro-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-8-oxa-3-azabicyclo[3.2.1]octane
収率 100%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒3 回

実験手順

Tert-butyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-chloro-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate (0.20 g, 0.45 mmol) was dissolved in dichloromethane (10 mL) and treated with trifluoroacetic acid (2 mL). When LC/MS analysis revealed the deprotection of the Boc group, the mixture was concentrated to dryness under reduced pressure. Diethyl ether was evaporated three times from the crude material in order to afford a solid residue. The trifluoroacetate salt was dissolved in dichloromethane (10 mL) and then treated with triethylamine (0.18 mL). The mixture was concentrated to dryness under reduced pressure. The residue was taken up in dichloromethane (10 mL) and treated with 3-pyridinecarboxaldehyde (0.064 mL). The mixture was allowed to stir for 10 minutes before the addition of sodium triacetoxyborohydride (0.15 g, 0.68 mmol). After stirring overnight, the mixture was diluted with dichloromethane and washed with 1 M aqueous sodium hydroxide solution. The aqueous phase was back extracted once with dichloromethane and then the combined organics were dried over anhydrous magnesium sulfate, filtered, and concentrated to dryness under reduced pressure. 3-(6-Chloro-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-8-oxa-3-azabicyclo[3.2.1]octane (0.20 g, 100%) was thus obtained as a yellow crystalline solid. MS (ES+): 440.0, 441.2 (M+H)+

後処理

  1. concentrationthe mixture was concentrated to dryness under reduced pressure
  2. customDiethyl ether was evaporated three times from the crude material in order
  3. customto afford a solid residue
  4. concentrationThe mixture was concentrated to dryness under reduced pressure
  5. additiontreated with 3-pyridinecarboxaldehyde (0.064 mL)
  6. washwashed with 1 M aqueous sodium hydroxide solution
  7. extractionThe aqueous phase was back extracted once with dichloromethane
  8. dry with materialthe combined organics were dried over anhydrous magnesium sulfate
  9. filtrationfiltered
  10. concentrationconcentrated to dryness under reduced pressure

出典と根拠

ORDレコード
ord-aae8893ceeaf448594236f84cf8e8676
出典データセット
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08129371B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート